Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide, Rituximab, and High-dose Methotrexate in PCNSL
NCT04516655Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Sep 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tucidinostat in primary central nervous system lymphoma (PCNSL), sponsored by Fudan University. Status: unknown.
02
Drugs
tucidinostat
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT04516655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04516655.